Tulobuterol

妥洛特罗

Report date: 2025/03/25 09:40:08
NME

Base Information

Drug NameTulobuterol
Drug Alias NametulobuterolumHokunalin
ClassificationSmall molecules
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsAcute BronchitisRespiratory Distress Syndrome, AdultPulmonary Emphysema +[5] 
Global Approved IndicationsAcute BronchitisRespiratory Distress Syndrome, AdultPulmonary Emphysema +[5] 
Approved Indications in ChinaAcute BronchitisRespiratory Distress Syndrome, AdultPulmonary Emphysema +[5] 
Original Approved Country/TerritoryJapan
Original Approved Date1998/09/30
Country/TerritorySouth KoreaMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHokuriku Seiyaku Co LtdNitto Denko
China Registration ClassN/A

Develop Information

Active CompaniesAbbott LaboratoriesNitto Denko Corp
Inactive CompaniesN/A
Active IndicationsAcute BronchitisRespiratory Distress Syndrome, AdultPulmonary Emphysema +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeR03AC11R03CC11
Related LinksWikipediaDrugBankKEGG